Sparian Biosciences Receives $15M NIH Grant to support its programs addressing pain and substance use disorders.
Amount Raised
$15 Million
Round Type
Grant
New YorkBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Sparian Biosciences, a NYC-based clinical-stage biopharmaceutical company, received a $15M NIH Grant. This grant is the company's fifth NIH/NIDA grant awarded since its founding. Sparian focuses on developing therapies for pain and substance use disorders with a total of $75M in government grants since inception.
Quick answer
Sparian Biosciences raised $15 Million in a Grant round, dated April 13, 2026. Sparian Biosciences is based in New York, New York, United States.
- How much did Sparian Biosciences raise?
- Sparian Biosciences raised $15 Million in a Grant round on April 13, 2026.
- What does Sparian Biosciences do?
- Sparian Biosciences, Inc. (“Sparian”) is a clinical-stage CNS-focused biopharmaceutical company founded to develop innovative therapeutics to treat neurologic and neuropsychiatric conditions, with a focus on pain and..
- Where is Sparian Biosciences based and how big is it?
- Sparian Biosciences is based in New York, New York, United States. Fundz records about 4 employees.
- Who are the decision-makers at Sparian Biosciences?
- Fundz holds 2 contacts at Sparian Biosciences, including the Chief Operating Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Sparian Biosciences that raised within 45 days of this round, from Fundz verified event records.
- HCW Biologics raised $4M on May 21, 2026.
- Citius Oncology raised $37M on May 6, 2026.
- Windward Bio raised $165M (Funding Round) on May 5, 2026.
- Lighthouse Pharmaceuticals raised $15M (Series A) on April 22, 2026.
- Sidewinder Therapeutics raised $137M (Series B) on April 8, 2026.
- Denali Therapeutics raised $200M (Debt Financing) on March 31, 2026.
Who to call at Sparian Biosciences, and when
A new round usually means Sparian Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sparian Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sparian Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sparian Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sparian Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sparian Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.